PTPN11 and hepatocellular carcinoma: These data suggest that the anti-parallel NF-κB–SHP2 and STAT signaling pathways are competitively active in precancerous inflammatory liver tissues, but their activities are lost simultaneously upon transformation of liver cells during HCC development.